ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0114

Platelets Are Highly Activated and Could Participate in Immune Abnormality of APS

Yu Shi1, Xiaofan Luo2, Quan Chen3, Jiuliang zhao4, Mengtao Li4 and xiaofeng Zeng5, 1Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Nankai University, Tianjin, China, 3Nankai University, Beijing, China, 4Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 5Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Meeting: ACR Convergence 2023

Keywords: antiphospholipid syndrome, Gene Expression, Mitochondrial Dysfunction, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0096–0116) Antiphospholipid Syndrome Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Platelets play a pivotal role in the process of coagulation and other biological process. Studies have shown multiple evidences that platelets are highly activated in APS, and have the ability to enhance the activity of other cells like endothelial cells, monocytes, and neutrophils. Emerging evidences have indicated that platelets are more than a part of coagulation process.

Methods: We included 35 patients who fulfilled the 2006 Sydney classification criteria of APS and 18 age, sex matched heathy controls (HC). Activation of platelet was measured by flow cytometry. Reactive oxygen species (ROS) production and mitochondrial respiration was measured. RNA-sequencing was performed.

Results: The baseline characteristics of studied patients are shown in Table 1. Platelet activation was detected by the surface expression of CD62p after gating with CD41a. As presented in Figure 1A, the mean fluorescent intensity of CD62p was significantly increased in APS patients compared with HC (p< 0.05) . After stimulated with adenosine diphosphate (ADP, 0.1U/ml) and thrombin (2U/ml), the activation was similar between patients and HC. Previous research showed platelets treated with immune thrombocytopenia plasma was induced to shed GPIbα(CD42b), so we examined the surface expression of CD42b and found no statistic difference (Figure 1B). Then we detected the ROS production (Figure 1C-D)and found that platelets of APS patients both in original state and activated with thrombin produced significantly more ROS than the HC. Then we want to explore if platelets from APS patients contain more mitochondria or it is because the metabolism is more activated. Mitotracker was used to label mitochondria in platelets. As shown in Figure1E, the quantity of mitochondria was similar. We used seahorse analysis to examine mitochondrial respiration and found that maximum respiration was evidently higher in platelets from APS patients (Figure 1F).

We performed RNA sequencing in 14 APS patients and 6 age, sex matched HC. 748 differently expressed genes with adjusted p-value < 0.01 and |log2FoldChange| > 1.5 were screened and tested enrichment in KEGG pathways (Figure 2). It is evident that multiple immune related pathways were enriched including inflammatory signaling pathways (JAK-STAT, IL-17 signaling pathways) and T cell associated pathways (Th1, Th2, and Th17 differentiation).

Conclusion: Platelet activation and mitochondrial respiration is highly increased in APS. The platelet transcriptome of APS is significantly different from HC. Platelets could interact as immune cells to modulate T cell activity.

Supporting image 1

Table 1. Baseline demographic, clinical, and laboratory characteristics of study patients.

Supporting image 2

Figure 1. Platelet flow cytometry and mitochondrial respiration of study patients.

Supporting image 3

Figure 2. KEGG pathway enrichment of differently expressed genes from platelet RNA sequencing.


Disclosures: Y. Shi: None; X. Luo: None; Q. Chen: None; J. zhao: None; M. Li: None; x. Zeng: None.

To cite this abstract in AMA style:

Shi Y, Luo X, Chen Q, zhao J, Li M, Zeng x. Platelets Are Highly Activated and Could Participate in Immune Abnormality of APS [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/platelets-are-highly-activated-and-could-participate-in-immune-abnormality-of-aps/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/platelets-are-highly-activated-and-could-participate-in-immune-abnormality-of-aps/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology